$136.000 value
$138.00 (15%
off)VIPapplied$136.000
Institutional ownership in GDRX has increased to 45%, bolstering the forecast that larger fund participation will add price stability and reduce volatility in upcoming market sessions. Additional sales over the last two years increased its profitability as the 32.1% annual growth in its earnings per share outpaced its revenue operates a digital platform that helps consumers find lower prices on prescription medications through price comparison tools and discount codes. Historical data analysis for GDRX shows post-earnings drift averaging 4% over two weeks. If trend persists, short-term price forecast leans toward testing resistance near $9.
Offers & perks
Join Star Rewards & get
free shipping at $39
Exclusions